GlassScriptPhysician profile
Arthur W Bracey
NPI 1245291764
$8,162.62
in general payments reported to CMS, 2019-2025
14 companies · none reported in 2025
See the full distribution for Blood Banking & Transfusion Medicine
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,055 · 2020: $185 · 2021: $3,523 · 2022: $296 · 2023: $2,926 · 2024: $177.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,022 · Food and Beverage: $1,081.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,022.17 |
| Food and Beverage | $1,080.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $3,937.48 | 2019-2023 | |
| Cerus Corporation | $1,844.47 | 2019-2023 | Intercept Blood System For Platelets |
| American National Red Cross | $1,783.92 | 2019-2023 | |
| Rigel Pharmaceuticals, INC. | $110.96 | 2020 | |
| Biomerieux INC | $108.64 | 2022 | |
| Agios Pharmaceuticals, INC. | $89.65 | 2019-2024 | Pyrukynd |
| Labcorp Holdings INC. | $73.00 | 2024 | Pgdx Elio Tissue Complete |
| Werfen USA LLC | $46.94 | 2022 | |
| Amgen INC. | $41.68 | 2019-2020 | |
| Celgene Corporation | $38.32 | 2019 | |
| Sanofi-Aventis U.S. LLC | $30.75 | 2020 | |
| Abbott Laboratories | $29.43 | 2024 | Alinity |
| Alexion Pharmaceuticals, INC. | $13.99 | 2019 | |
| Octapharma USA, INC. | $13.39 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arthur Bracey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.